Organic Letters
Letter
Scheme 5. Synthesis of Citalopram
REFERENCES
■
́
(1) Lorente, A.; Lamariano-Merketegi, J.; Albericio, F.; Alvarez, M.
Chem. Rev. 2013, 113, 4567.
(2) Bermejo, A.; Figadere, B.; Zafra-Polo, M.-C.; Barrachina, I.;
Estornell, E.; Cortes, D. Nat. Prod. Rep. 2005, 22, 269.
(3) Welsch, M. E.; Snyder, S. A.; Stockwell, B. R. Curr. Opin. Chem.
Biol. 2010, 14, 347.
(4) Selected reviews: (a) Laya, M. S.; Banerjee, A. K.; Cabrera, E.
V. Curr. Org. Chem. 2009, 13, 720. (b) Ranganathan, S.;
Muraleedharan, K. M.; Vaish, N. K.; Jayaraman, N. Tetrahedron
2004, 60, 5273. (c) French, A. N.; Bissmire, S.; Wirth, T. Chem. Soc.
Rev. 2004, 33, 354.
(5) Selected reviews: Tiecco, M.; Testaferri, L.; Bagnoli, L.; Marini,
F.; Santi, C.; Temperini, A.; Scarponi, C.; Sternativo, S.; Terlizzi, R.;
Tomassini, C. ARKIVOC 2006, vii, 186. (b) Petragnani, N.; Stefani,
H. A.; Valduga, C. J. Tetrahedron 2001, 57, 1411. (c) Tiecco, M. In
Topics in Current Chemistry: Organoselenium Chemistry; Wirth, T.,
Ed.; Springer: Heidelberg, 2000; pp 7−54.
(6) For example: Dhokte, U. P.; Rao, A. S. Org. Prep. Proced. Int.
1992, 24, 13.
(7) Tiecco, M.; Testaferri, L.; Tingoli, M. Tetrahedron 1993, 49,
5351.
(8) For example: (a) Zhang, Y.; Ye, Q.; Wang, X.; She, B.-Q.;
Thorson, J. S. Angew. Chem., Int. Ed. 2015, 54, 11219. (b) Zheng, T.;
Narayan, R. S.; Schomaker, J. M.; Borhan, B. J. Am. Chem. Soc. 2005,
127, 6946.
(9) Rawling, M. J.; Tomkinson, N. C. O. Org. Biomol. Chem. 2013,
11, 1434.
(10) (a) Griffith, J. C.; Jones, K. M.; Picon, S.; Rawling, M. J.;
Kariuki, B. M.; Campbell, M.; Tomkinson, N. C. O. J. Am. Chem.
Soc. 2010, 132, 14409. (b) Jones, K. M.; Tomkinson, N. C. O. J. Org.
Chem. 2012, 77, 921.
(11) Rawling, M. J.; Rowley, J. H.; Campbell, M.; Kennedy, A. R.;
Parkinson, J. A.; Tomkinson, N. C. O. Chem. Sci. 2014, 5, 1777.
(12) Alamillo-Ferrer, C.; Davidson, S. C.; Rawling, M. J.;
Theodoulou, N. H.; Campbell, M.; Humphreys, P. G.; Kennedy,
A. R.; Tomkinson, N. C. O. Org. Lett. 2015, 17, 5132.
(13) Picon, S.; Rawling, M.; Campbell, M.; Tomkinson, N. C. O.
Org. Lett. 2012, 14, 6250.
In summary, we have developed a simple and effective
stereoselective oxidative cyclization method for the prepara-
tion of γ-lactones, isobenzofuranones, and tetrahydrofurans.
The reactions proceed under very mild conditions, forming
two new carbonoxygen σ bonds and further extend the
applications of malonoyl peroxides in synthesis.22 The
stereochemical outcome of the reaction can be changed
simply by altering the stereochemistry of the starting alkene to
deliver either the trans- or cis-products. Application of this
method within a transition-metal-free preparation of citalo-
pram 47 shows the applicability of the transformation to the
preparation of important active pharmaceutical agents. Use of
this generic process to prepare alternative heterocyclic
architectures is ongoing, and we will report on our findings
in due course.
(14) For reviews on the use of fluorinated alcohols in organic
synthesis see: (a) Shuklov, I. A.; Dubrovina, N. V.; Borner, A.
̈
Synthesis 2007, 2925. (b) Beg
B. Synlett 2004, 18.
́ ́
ue, J.-P.; Bonnet-Delpon, D.; Crousse,
(15) Adam, W.; Rucktaschel, R. J. Org. Chem. 1972, 37, 4128.
̈
(16) (a) Baldwin, J. E. J. Chem. Soc., Chem. Commun. 1976, 734.
(b) Alabugin, I. V.; Gilmore, K. Chem. Commun. 2013, 49, 11246.
(17) Lin, G.; Chan, S. S. K.; Chung, H. S.; Li, S. L. Chemistry and
Biological Action of Natural Occurring Phthalides. In Studies in
Natural Products Chemistry Atta-ur-Rahman, Ed.; Elsevier: Amster-
dam, 2005; Vol. 32; pp 611−669.
ASSOCIATED CONTENT
* Supporting Information
■
S
The Supporting Information is available free of charge on the
optimization.
(19) Beesley, R. M.; Ingold, C. K.; Thorpe, J. F. J. Chem. Soc.,
Trans. 1915, 107, 1080.
(20) Roberts, P. J.; Castaner, J.; Serradell, M. N.; Blancafort, P.
Drugs Future 1979, 4, 407.
Analytical data, experimental procedures, and NMR
spectra for all compounds reported (PDF)
X-ray crystallogrphic data for 16, 23, and 29 (CIF)
(21) Hewitt, J. F. M.; Williams, L.; Aggarwal, P.; Smith, C. D.;
France, D. J. Chem. Sci. 2013, 4, 3538.
AUTHOR INFORMATION
Corresponding Author
■
(22) For recent examples of the use of malonoyl peroxides see:
(a) Terent’ev, A. O.; Vil, V. A.; Gorlov, E. S.; Nikishin, G. I.;
Pivnitsky, K. K.; Adam, W. J. Org. Chem. 2016, 81, 810. (b) Dragan,
A.; Kubczyk, T. M.; Rowley, J. H.; Sproules, S.; Tomkinson, N. C. O.
Org. Lett. 2015, 17, 2618. (c) Terent’ev, A. O.; Vil, V. A.; Mulina, O.
M.; Pivnitsky, K. K.; Nikishin, G. I. Mendeleev Commun. 2014, 24,
345.
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We thank EPSRC, GlaxoSmithKline, and CNPq for financial
support and the EPSRC Mass Spectrometry Service, Swansea,
for high-resolution spectra.
D
Org. Lett. XXXX, XXX, XXX−XXX